vs
DLH Holdings Corp.（DLHC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
DLH Holdings Corp.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.9倍（$68.9M vs $35.5M），DLH Holdings Corp.净利率更高（-1.9% vs -304.2%，领先302.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -24.1%），DLH Holdings Corp.自由现金流更多（$-4.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -17.4%）
DLH Holdings Corp.是一家总部位于美国的政府服务供应商，主要为退伍军人事务部、国防部、卫生与公众服务部等联邦机构提供技术赋能的医疗、物流、工程及任务支持服务，同时服务部分州及地方公共部门客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
DLHC vs RXRX — 直观对比
营收规模更大
DLHC
是对方的1.9倍
$35.5M
营收增速更快
RXRX
高出705.9%
-24.1%
净利率更高
DLHC
高出302.3%
-304.2%
自由现金流更多
DLHC
多$42.5M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-17.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $68.9M | $35.5M |
| 净利润 | $-1.3M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 2.1% | -304.8% |
| 净利率 | -1.9% | -304.2% |
| 营收同比 | -24.1% | 681.7% |
| 净利润同比 | -218.7% | 39.6% |
| 每股收益（稀释后） | $-0.09 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DLHCRXRX
| Q4 25 | $68.9M | $35.5M | ||
| Q3 25 | $81.2M | $5.2M | ||
| Q2 25 | $83.3M | $19.2M | ||
| Q1 25 | $89.2M | $14.7M | ||
| Q4 24 | $90.8M | $4.5M | ||
| Q3 24 | $96.4M | $26.1M | ||
| Q2 24 | $100.7M | $14.4M | ||
| Q1 24 | $101.0M | $13.8M |
净利润DLHCRXRX
| Q4 25 | $-1.3M | $-108.1M | ||
| Q3 25 | $-920.0K | $-162.3M | ||
| Q2 25 | $289.0K | $-171.9M | ||
| Q1 25 | $878.0K | $-202.5M | ||
| Q4 24 | $1.1M | $-178.9M | ||
| Q3 24 | $2.3M | $-95.8M | ||
| Q2 24 | $1.1M | $-97.5M | ||
| Q1 24 | $1.8M | $-91.4M |
毛利率DLHCRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率DLHCRXRX
| Q4 25 | 2.1% | -304.8% | ||
| Q3 25 | 2.8% | -3327.6% | ||
| Q2 25 | 4.5% | -916.8% | ||
| Q1 25 | 5.7% | -1297.9% | ||
| Q4 24 | 6.2% | -4042.4% | ||
| Q3 24 | 6.6% | -377.1% | ||
| Q2 24 | 5.7% | -697.4% | ||
| Q1 24 | 5.9% | -698.4% |
净利率DLHCRXRX
| Q4 25 | -1.9% | -304.2% | ||
| Q3 25 | -1.1% | -3135.3% | ||
| Q2 25 | 0.3% | -894.2% | ||
| Q1 25 | 1.0% | -1373.3% | ||
| Q4 24 | 1.2% | -3935.5% | ||
| Q3 24 | 2.4% | -367.5% | ||
| Q2 24 | 1.1% | -676.6% | ||
| Q1 24 | 1.8% | -662.4% |
每股收益（稀释后）DLHCRXRX
| Q4 25 | $-0.09 | $-0.17 | ||
| Q3 25 | $-0.07 | $-0.36 | ||
| Q2 25 | $0.02 | $-0.41 | ||
| Q1 25 | $0.06 | $-0.50 | ||
| Q4 24 | $0.08 | $-0.56 | ||
| Q3 24 | $0.16 | $-0.34 | ||
| Q2 24 | $0.08 | $-0.40 | ||
| Q1 24 | $0.12 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.0K | $743.3M |
| 总债务越低越好 | $133.5M | $9.6M |
| 股东权益账面价值 | $112.2M | $1.1B |
| 总资产 | $283.5M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.19× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资DLHCRXRX
| Q4 25 | $257.0K | $743.3M | ||
| Q3 25 | $125.0K | $659.8M | ||
| Q2 25 | $194.0K | $525.1M | ||
| Q1 25 | $196.0K | $500.5M | ||
| Q4 24 | $451.0K | $594.4M | ||
| Q3 24 | $342.0K | $427.6M | ||
| Q2 24 | $423.0K | $474.3M | ||
| Q1 24 | $238.0K | $296.3M |
总债务DLHCRXRX
| Q4 25 | $133.5M | $9.6M | ||
| Q3 25 | $128.0M | $11.9M | ||
| Q2 25 | $138.3M | $14.2M | ||
| Q1 25 | $147.3M | $16.4M | ||
| Q4 24 | $162.2M | $19.0M | ||
| Q3 24 | $149.4M | $20.5M | ||
| Q2 24 | $160.9M | $22.9M | ||
| Q1 24 | $164.8M | — |
股东权益DLHCRXRX
| Q4 25 | $112.2M | $1.1B | ||
| Q3 25 | $113.0M | $1.0B | ||
| Q2 25 | $113.7M | $919.1M | ||
| Q1 25 | $112.8M | $933.9M | ||
| Q4 24 | $111.4M | $1.0B | ||
| Q3 24 | $110.1M | $524.6M | ||
| Q2 24 | $108.6M | $584.4M | ||
| Q1 24 | $106.8M | $401.2M |
总资产DLHCRXRX
| Q4 25 | $283.5M | $1.5B | ||
| Q3 25 | $290.7M | $1.4B | ||
| Q2 25 | $299.3M | $1.3B | ||
| Q1 25 | $306.6M | $1.3B | ||
| Q4 24 | $325.0M | $1.4B | ||
| Q3 24 | $314.4M | $726.5M | ||
| Q2 24 | $325.0M | $775.9M | ||
| Q1 24 | $325.9M | $557.8M |
负债/权益比DLHCRXRX
| Q4 25 | 1.19× | 0.01× | ||
| Q3 25 | 1.13× | 0.01× | ||
| Q2 25 | 1.22× | 0.02× | ||
| Q1 25 | 1.31× | 0.02× | ||
| Q4 24 | 1.46× | 0.02× | ||
| Q3 24 | 1.36× | 0.04× | ||
| Q2 24 | 1.48× | 0.04× | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-4.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | -7.0% | -133.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $29.2M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流DLHCRXRX
| Q4 25 | $-4.8M | $-46.1M | ||
| Q3 25 | $10.7M | $-117.4M | ||
| Q2 25 | $9.6M | $-76.4M | ||
| Q1 25 | $14.5M | $-132.0M | ||
| Q4 24 | $-11.5M | $-115.4M | ||
| Q3 24 | $12.4M | $-59.2M | ||
| Q2 24 | $4.6M | $-82.2M | ||
| Q1 24 | $5.2M | $-102.3M |
自由现金流DLHCRXRX
| Q4 25 | $-4.8M | $-47.3M | ||
| Q3 25 | $10.7M | $-117.6M | ||
| Q2 25 | $9.4M | $-79.6M | ||
| Q1 25 | $14.0M | $-133.8M | ||
| Q4 24 | $-12.1M | $-116.7M | ||
| Q3 24 | $12.2M | $-63.8M | ||
| Q2 24 | $4.5M | $-83.4M | ||
| Q1 24 | $4.9M | $-109.0M |
自由现金流率DLHCRXRX
| Q4 25 | -7.0% | -133.1% | ||
| Q3 25 | 13.1% | -2272.5% | ||
| Q2 25 | 11.2% | -413.9% | ||
| Q1 25 | 15.6% | -907.4% | ||
| Q4 24 | -13.3% | -2567.7% | ||
| Q3 24 | 12.7% | -244.6% | ||
| Q2 24 | 4.4% | -578.5% | ||
| Q1 24 | 4.9% | -789.9% |
资本支出强度DLHCRXRX
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.3% | 16.4% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 0.6% | 28.6% | ||
| Q3 24 | 0.2% | 17.5% | ||
| Q2 24 | 0.2% | 8.2% | ||
| Q1 24 | 0.3% | 48.2% |
现金转化率DLHCRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 33.12× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | -10.35× | — | ||
| Q3 24 | 5.42× | — | ||
| Q2 24 | 4.06× | — | ||
| Q1 24 | 2.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DLHC
| Sales Channel Directly To Consumer | $64.5M | 94% |
| Sales Channel Through Intermediary | $4.4M | 6% |
RXRX
暂无分部数据
